Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Amgen To Participate In Citi Biotech R&D Conference Call

Posted on: 04 Oct 16

PR Newswire

THOUSAND OAKS, Calif., Oct. 4, 2016

THOUSAND OAKS, Calif., Oct. 4, 2016 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will participate in a call hosted by Citi at 8 a.m. PT on Friday, Oct. 7, 2016. Sean E. Harper, M.D., executive vice president of Research and Development (R&D) at Amgen, will discuss recent developments within the Company's R&D. Live audio of the call can be accessed from the Events Calendar on Amgen's website,, under Investors. A replay of the webcast will also be available on Amgen's website for at least 90 days following the event.

About Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. 

For more information, visit and follow us on

CONTACT: Amgen, Thousand Oaks
Kristen Davis, 805-447-3008 (media)
Kristen Neese, 805-313-8267 (media)
Arvind Sood, 805-447-1060 (investors)

Logo -


To view the original version on PR Newswire, visit:


PR Newswire

Last updated on: 04/10/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.